Table V.
Comparison of HGF and MCP-1 mRNA expression in the cells of each group (mean ± SD).
| Groups | n | HGF mRNA/GAPDH mRNA | MCP-1 mRNA/GAPDH mRNA |
|---|---|---|---|
| Control | 10 | 0.4760±0.135b | 1.357±0.594 |
| TGF-β1 | 10 | 2.4975±0.826a | 10.314±0.931a |
| High-dose | 10 | 13.9810±1.584a–c | 4.712±0.821a–d |
| Low-dose | 10 | 7.1250±1.038a,b | 5.367±1.187a,b |
| Fosinopril | 10 | 20.0910±2.0138a,b | 2.631±0.835a,b |
a
P<0.01, compared with the control group;
b
P<0.01, compared with the model group;
c
P<0.01, high-dose group compared with the low-dose group;
d
P>0.05, high-dose group compared with the fosinopril group. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HGF, hepatocyte growth factor; MCP-1, monocyte chemotactic protein-1.